Physician

Anesthesiology

Mohammad Iqbal works in the field of Anesthesiology. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Dr. Mohammad S. Iqbal is a published physician as well. He has 40 publications published. The latest was: Gold levels produced by treatment with auranofin and sodium aurothiomalate. He accepts all Medicare patients.

Publications

---

• Fabrication of potential macromolecular prodrugs of aspirin and diclofenac with dextran.
• Antibacterial dimeric copper(II) complexes with chromone-derived compounds.
• Comparative study of pharmaceutical properties of some new derivatives of sulfamethoxazole.
• Mechanochemical synthesis and in vitro anti-Helicobacter pylori and uresase inhibitory activities of novel zinc(II)-famotidine complex.
• 4-(2-Ethyl-phen-yl)-1-(2-oxoindolin-3-yl-idene)thio-semicarbazide.
• 4-(3-Nitro-phen-yl)-1-(2-oxoindolin-3-yl-idene)thio-semicarbazide.
• 4-(3-Methoxy-phen-yl)-1-(2-oxoindolin-3-yl-idene)thio-semicarbazide.
• 4-(2-Fluoro-phen-yl)-1-(2-oxoindolin-3-yl-idene)thio-semicarbazide.
• 1-(2-Oxoindolin-3-yl-idene)-4-[2-(trifluoro-meth-oxy)phen-yl]thio-semi-carbazide.
• 1-[2-Oxo-5-(trifluoro-meth-oxy)indolin-3-yl-idene]-4-[4-(trifluoro-methyl)-phen-yl]thio-semicarbazide.
• 4-(5-Chloro-2-methyl-phen-yl)-1-[2-oxo-5-(trifluoro-meth-oxy)indolin-3-yl-idene]thio-semicarbazide.
• Methyl 2-methyl-3,5-dinitro-benzoate.
• In vitro distribution of gold in serum proteins after incubation of sodium aurothiomalate and auranofin with human blood and its pharmacological significance.
• A simple method for simultaneous determination of some organic liquids in in-process materials and effluents produced in the manufacture of amoxicillin and ampicillin.
• N''-[(1E)-1-(4-Chloro-phen-yl)ethyl-idene]formohydrazide.
• N''-[(E)-(4-Bromo-2-thien-yl)methyl-idene]benzohydrazide 0.06-hydrate.
• N''-[(E)-(4-Bromo-2-thienyl)methyl-ene]isonicotinohydrazide.
• N''-[(E)-4-Hydr-oxy-3-methoxy-benzyl-idene]pyridine-4-carbohydrazide.
• N''-[(E)-4-Hydr-oxy-3-methoxy-benzyl-idene]benzohydrazide.
• N''-[(E)-1-(3-Fluoro-phen-yl)ethyl-idene]formohydrazide.
• (Z)-4-Hexyl-1-(5-nitro-2-oxo-2,3-dihydro-1H-indol-3-yl-idene)thio-semicarbazide.
• 1-(5-Nitro-2-oxoindolin-3-yl-idene)-4-o-tolyl-thio-semicarbazide methanol monosolvate.
• N''-[(E)-(5-Methyl-furan-2-yl)methyl-idene]formohydrazide.
• (2-Amino-phen-yl)[(5S)-5-hydr-oxy-3,5-dimethyl-4,5-dihydro-1H-pyrazol-1-yl]methanone.
• 3-Amino-2-methyl-4-oxo-3,4-dihydro-quinazolin-1-ium p-toluene-sulfonate monohydrate.
• 2-[6-Thioxo-5-(2,4,6-trimethyl-phen-yl)-1,3,5-thia-diazinan-3-yl]acetic acid.
• 3-Benzyl-5-butyl-1,3,5-thia-diazinane-2-thione.
• (2R)-2-(1,3-Dioxoisoindolin-2-yl)-4-(methyl-sulfan-yl)butanoic acid.
• 2-Hydr-oxy-3-nitro-benzamide.
• 2-Hydr-oxy-5-nitro-benzamide.
• 3-Hydr-oxy-N''-[(Z)-(5-methyl-2-fur-yl)methyl-idene]naphthalene-2-carbo-hydrazide.
• Mutual prodrug of cephazolin and benzydamin: 3-[(1-benzyl-1H-indazol-3-yl)-oxy]-N,N-dimethyl-propan-1-aminium 3-{[(5-methyl-1,3,4-thia-diazol-2-yl)sulfan-yl]meth-yl}-8...
• In vitro cytotoxic, antibacterial, antifungal and urease inhibitory activities of some N4- substituted isatin-3-thiosemicarbazones.
• Pharmacokinetic study of copper (II) acetylsalicylate.
• Degradation of atorvastatin: (1R,2S,4S,5S)-4-(4-fluoro-phen-yl)-2-hydro-peroxy-4-hydr-oxy-2-isopropyl-N,5-diphenyl-3,6-dioxabicyclo-[3.1.0]hexane-1-carboxamide.
• 3-(2-Benzamido-phen-yl)-4-(4-hydroxy-phen-yl)-5-methyl-4H-1,2,4-triazol-1-ium chloride.
• Erythrocyte membrane gold levels after treatment with auranofin and sodium aurothiomalate.
• Synthesis of some N4-substituted isatin-3-thiosemicarbazones.
• Gold levels produced by treatment with auranofin and sodium aurothiomalate.

Doctors Specialties

---

• Anesthesiology
• Pain Medicine Anesthesiology

Accepted Insurances

---

Awards

---

• CMS Meaningful Use Stage 1 Certification

Drug Facts

---

NPI NUMBER		1235137340
NPPES Provider LastName		IQBAL
NPPES Provider FirstName		MOHAMMAD
NPPES Provider ZIPCode		503143034
NPPES Provider State		IA
Specialty Description		Interventional Pain Management
Total Claim Count		2239.0
Distinct Opioid Count		14.0
Opioid Claim Count		1346.0
Percent Opioid Claims		60.12

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1235137340
Last Name Of The Provider	IQBAL
First Name Of The Provider	MOHAMMAD
View All

Similar Doctors

---

	Dr. John U. Skoog, MD This Doctor is OpenDoctor Recommended.
	Dr. Myrdalis A. Diaz-Ramirez, MD This Doctor is OpenDoctor Recommended.
	Dr. Mark D. Woiwood, MD This Doctor is OpenDoctor Recommended.
	Dr. Zane Hurkin, DO
	Dr. Darin L. Frerichs, DO This Doctor is OpenDoctor Recommended.
	Dr. Thomas Monachino, MD This Doctor is OpenDoctor Recommended.
	Dr. Blythe E. Harris, MD This Doctor is OpenDoctor Recommended.
	Dr. Josef A. Granwehr, MD
	Dr. George Lederhaas, MD This Doctor is OpenDoctor Recommended.
	Dr. John C. Jabour, MD This Doctor is OpenDoctor Recommended.
	Dr. Brent R. Thurness, MD This Doctor is OpenDoctor Recommended.
	Dr. Louis J. Dewild, MD This Doctor is OpenDoctor Recommended.
	Dr. Kenton J. Hall, MD This Doctor is OpenDoctor Recommended.
	Dr. Nicholas J. Aerisolphal, MD
	Dr. Daniel M. Waller, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog